PPCB vs SBUX · P/E 0.0, $3.9M cap vs P/E 76, rev $37.18B
Propanc Biopharma, Inc. Common Stock (PPCB) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
PPCB does not have a complete income-statement cache yet.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the PPCB and SBUX stock pages for the full models.
Not investment advice.